Salomon Azoulay, M.D., serves as the Chief Medical Officer and Head of Research and Development of Sumitovant. In this role he oversees numerous functions including clinical development, CMC, Regulatory, and medical affairs functions. Dr. Azoulay has served as Chief Medical Officer of Roivant Sciences since May 2018. He joined Roivant from Pfizer, where he most recently served as Senior Vice President and Chief Medical Officer for Pfizer Essential Health. In that role he oversaw clinical development and medical affairs for a portfolio that included over 600 branded products as well as biosimilars and sterile injectables. He has over 25 years of experience in the biopharmaceutical industry and held senior leadership roles at Pfizer since 2001, including Head of Development in Japan and Senior Vice President for Medical and Development in Emerging Markets.